COMPANY PROFILE / #3027
BiomEdit
Indianapolis, INVenture Capital-Backed
OVERVIEW
Developer of programmable veterinary biologics designed to address livestock health and productivity challenges as well as chronic diseases in pets. The company offers engineered biological products with programmable therapeutic capabilities, enabling livestock producers and pet healthcare providers to improve animal health outcomes and productivity.
已融资55.10
最新估值45.00
员工数30
成立年份2022
公司概况
- Companies
- BiomEdit
- Description
- Developer of programmable veterinary biologics designed to address livestock health and productivity challenges as well as chronic diseases in pets. The company offers engineered biological products with programmable therapeutic capabilities, enabling livestock producers and pet healthcare providers to improve animal health outcomes and productivity.
- Website
- www.biomedit.com
- HQ Location
- Indianapolis, IN
- Year Founded
- 2022
- Keywords
- animal biotech, animal biotechnology, animal health product, immune modulation, microbiome research, microbiome test, synthetic biology
- Competitors
- Native Microbials, Bactolife, AnimalBiome, Resilient Biotics, Eligo Bioscience, AgThera, Novobind, Axiota Animal Health, Folium Science
- Ownership Status
- Privately Held (backing)
- Company Financing Status
- Venture Capital-Backed
融资与估值
- Total Raised
- 55.10
- First Financing Date
- 11-Apr-2022
- First Financing Size
- —
- First Financing Valuation
- —
- Last Financing Date
- —
- Last Financing Deal Type
- Later Stage VC
- Last Financing Size
- 30.00
- Last Financing Valuation
- —
- Last Financing Status
- Upcoming
- Last Known Valuation
- 45.00
- Last Known Valuation Date
- 15-Jul-2025
- Last Known Valuation Deal Type
- Early Stage VC
- Valuation Estimate
- 64.06
- Valuation Estimate Growth Rate
- 42.35%
- Active Investors
- AgriZeroNZ, Anterra Capital, Betagro Ventures, Bezos Earth Fund, Elanco Animal Health, Elevate Ventures, Ferment, Gates Foundation, Ginkgo Bioworks, Nutreco, Viking Global Investors
- # Active Investors
- 11
- Acquirers
- —
团队与联系人
- Employees
- 30
- Employee Growth %
- 11.11%
- Employee History
- 2026: 30, 2025: 27, 2024: 37, 2023: 30, 2022: 25
- Primary Contact
- Aaron Schacht
- Primary Contact Title
- Founder, Chief Executive Officer & Board Member
- Primary Contact Email
- aaron@biomedit.com
- Primary Contact Phone
- +1 (317) 997-6844
增长与经营
- Revenue
- —
- Revenue Growth %
- —
- Growth Rate
- -1.17%
- Growth Rate % Change
- —
- Growth Rate Percentile
- 3
- Size Multiple
- 3.75x
- Size Multiple % Change
- 0.00%
- Size Multiple Change
- 0.00x
- Size Multiple Percentile
- 77
- Majestic Referring Domains
- —
- SimilarWeb Unique Visitors
- 0
- SimilarWeb Unique Visitors Change
- 0
- SimilarWeb Growth Rate
- —
- SimilarWeb Growth Rate Percentile
- —
- Success Probability Over Time – 1 Year
- 12%
- Success Probability Over Time – 3 Year
- 32%
- Success Probability Over Time – 5 Year
- 48%
记录来源：public.companies · 原始序号 #3027 · 所有字段均按数据库原值展示。